Company Quick10K Filing
Old Republic
10-Q 2021-03-31 Filed 2021-04-30
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-10-30
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-01
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-02-28
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-03
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-02-28
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-04
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-10-30
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-10-31
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-03-03
10-Q 2013-09-30 Filed 2013-11-01
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-02
10-Q 2012-06-30 Filed 2012-08-03
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-02
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-05
10-K 2009-12-31 Filed 2010-03-01
8-K 2020-10-22
8-K 2020-07-23
8-K 2020-07-16
8-K 2020-05-22
8-K 2020-04-23
8-K 2020-04-15
8-K 2020-03-30
8-K 2020-03-12
8-K 2020-02-26
8-K 2020-02-26
8-K 2020-01-23
8-K 2019-12-11
8-K 2019-10-24
8-K 2019-10-01
8-K 2019-08-21
8-K 2019-08-21
8-K 2019-07-25
8-K 2019-05-24
8-K 2019-05-09
8-K 2019-04-25
8-K 2019-01-30
8-K 2019-01-24
8-K 2018-10-25
8-K 2018-08-23
8-K 2018-07-26
8-K 2018-05-25
8-K 2018-04-26
8-K 2018-03-15
8-K 2018-01-25
8-K 2017-12-31

Old Republic Financials

ORI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1271181099311710912610112311315615313014622013715012816016013716914514617719513912610310811510093100110
Accounts Receivable
Inventory
PP&E
Assets15,88316,30415,99916,05016,16515,87516,18816,22716,41116,29916,52616,53416,81117,18416,98716,98817,20117,27717,32817,11017,43317,99118,81118,59218,90519,35719,74719,40418,99919,45419,80219,32720,29720,98821,182
Accounts Payable
Long-Term Debt
Liabilities11,76112,25412,17112,27812,39212,16312,49712,63112,73712,71512,81012,75912,94513,23113,06413,06413,18713,34013,47413,23013,29113,61314,36414,12014,30914,69515,01714,67013,95014,35114,49114,18114,63115,09415,388
Stockholders' Equity4,1213,8283,7723,7733,7123,6903,5963,6733,5843,7163,7753,8663,9533,9233,9244,0143,9373,8543,8814,1434,3784,4464,4724,5974,6624,7304,7335,0495,1035,3115,1465,6665,8945,794
Income Statement ($MM)2010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,1301,1141,3081,1581,2241,3051,2831,2701,4621,3801,3321,4311,3341,3911,3751,3301,4101,5461,4801,4141,4421,4961,5491,4451,4991,5931,7261,3301,6311,7801,2811,8691,6451,771
Cost of Revenue
Gross Profit
R&D
SG&A
Tax1-66140-30281025850102893628505059515948535952103138554601064050
Net Income-11655083-15-20561941039519466866310310212691123101111132113102463004198275-106412166203
Cash Flow ($MM)2010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-5233498119221014313518122813537-54218919111326312212638238235146113263-69131156310136177353
Cash Investing-447-423292-130-189-72-101-92-192-10823268-227-127-89-150-84-12940-760-187-72-46-27296179-60-248-81-11416
Cash Financing490-45-48-382-46-44-50-44-45-38-50-44347-45-50-46-81-37-20-46498-47-42-49-47-40-332-92-54-63-56-360